NM-2201

From WikiMD's Wellnesspedia

NM-2201 is a synthetic cannabinoid that has been identified in herbal blends. Its name refers to the company that first synthesized it, NIMH. It is part of the indole class of cannabinoids.

Chemistry[edit | edit source]

NM-2201 is an indole-based synthetic cannabinoid that is presumed to be a potent agonist of the CB1 receptor and has been sold online as a designer drug. It is closely related to other indole-based synthetic cannabinoids like AM-2201 and 5F-PB-22.

Effects[edit | edit source]

The effects of NM-2201 are not well-studied. However, it is known to be a potent agonist of the CB1 receptor, which is the same receptor that THC, the primary psychoactive component of cannabis, binds to. This suggests that NM-2201 may have similar psychoactive effects to THC, although this has not been confirmed in scientific studies.

Legal Status[edit | edit source]

The legal status of NM-2201 varies by country. In the United States, it is a Schedule I controlled substance. In the United Kingdom, it is a Class B drug. In Canada, it is a Schedule II drug. In Japan, it is a controlled substance.

See Also[edit | edit source]

References[edit | edit source]


NM-2201 Resources

Find a healthcare provider anywhere in the world quickly and easily!

Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.


Contributors: Prab R. Tumpati, MD